Martin Madaus

Martin Madaus

Vorsitzender bei REPLIGEN CORPORATION

Vermögen: 2 Mio $ am 30.06.2026

66 Jahre
Health Technology
Commercial Services
Health Services

Profil

Martin D.
Madaus
is Chairman at Repligen Corp.
starting 2026.
Executive Chairman at Emulate, Inc. since 2020.
Director at Candela Corp., Massachusetts High Technology Council, Inc., Ultivue, Inc., Syntis Bio, Inc., and Candela Medical, Inc. since 2018.
Independent Director at Azenta, Inc. starting 2024.
Director at Unchained Labs LLC since 2021.
Director at Haemonetics Corp.
starting 2026.
Senior Operating Executive at The Carlyle Group Inc. since 2019.
Formerly Chairman, President & Chief Executive Officer at EMD Millipore Corp.
from 2010.
Chairman, President & Chief Executive Officer at Millipore SA from 2005 to 2010.
Chairman & Chief Executive Officer at Ortho-Clinical Diagnostics, Inc. from 2014 to 2019.
President & Chief Executive Officer at Roche Diagnostics Corp.
from 2000 to 2004.
Independent Director at Mettler-Toledo International, Inc. from 2011 to 2015.
Independent Director at Covidien Unlimited Co. from 2011 to 2014.
Independent Director at Standard BioTools, Inc. from 2022 to 2024.
Independent Director at Hologic, Inc. from 2024 to 2026.
Director at Quanterix Corp.
from 2010 to 2025.
Chief Operations Officer at Sherlock Biosciences, Inc. from 2020 to 2021.
Vice President-Business Development at Roche Molecular Systems, Inc. Education includes doctorates from Ludwig-Maximilians-Universität München in 1985 and The University of Veterinary Medicine Hanover.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
14.05.2026 8 392 ( 0,01 % ) 1 Mio $ 30.06.2026
24.07.2026 2 538 ( 0,01 % ) 190 350 $ 30.06.2026
05.02.2026 7 405 ( 0,02 % ) 188 976 $ 30.06.2026

Aktive Positionen von Martin Madaus

UnternehmenPositionBeginn
CANDELA MEDICAL, INC. Direktor/Vorstandsmitglied 01.05.2018
REPLIGEN CORPORATION Vorsitzender 13.03.2026
AZENTA, INC. Direktor/Vorstandsmitglied 30.01.2024
HAEMONETICS CORPORATION Direktor/Vorstandsmitglied 24.07.2026
THE CARLYLE GROUP INC. Corporate Officer/Principal 01.01.2019
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied 01.07.2021
Direktor/Vorstandsmitglied -
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ -
░░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░

Ehemalige bekannte Positionen von Martin Madaus

UnternehmenPositionEnde
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Martin Madaus im Detail an

Ausbildung von Martin Madaus

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

69

Beziehungen ersten Grades

31

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen31

Health Technology

Health Technology

Commercial Services

Health Technology

Health Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Technology Services

Health Technology

Commercial Services

Health Services

Commercial Services

Health Services

Commercial Services

Electronic Technology

Finance

Analytical Life Science & Diagnostics Association

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Martin Madaus